Teva mulls $2b sale of API activities – report
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is contemplating the sale of its lively ...
Read more
Copyright © 2023 Special Business Center.
Special Business Center is not responsible for the content of external sites.
Copyright © 2023 Special Business Center.
Special Business Center is not responsible for the content of external sites.